0001437749-17-018162.txt : 20171102 0001437749-17-018162.hdr.sgml : 20171102 20171102163025 ACCESSION NUMBER: 0001437749-17-018162 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171101 FILED AS OF DATE: 20171102 DATE AS OF CHANGE: 20171102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SANDBERG RICHARD A CENTRAL INDEX KEY: 0001245055 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 171172830 MAIL ADDRESS: STREET 1: 330 NEVEDA STREET CITY: NEWTON STATE: MA ZIP: 02460-1458 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ 4 1 rdgdoc.xml FORM 4 X0306 4 2017-11-01 0001586049 Oxford Immunotec Global PLC OXFD 0001245055 SANDBERG RICHARD A C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 Ordinary Shares 2017-11-01 4 M 0 2778 0.81 A 17778 D Ordinary Shares 2017-11-01 4 M 0 222 0.09 A 18000 D Ordinary Shares 2017-11-01 4 S 0 3000 13.35 D 15000 D Stock Option (Right to Buy) 0.81 2017-11-01 4 M 0 2778 0 D 2022-12-31 Ordinary Shares 2778 0 D Stock Option (Right to Buy) 0.09 2017-11-01 4 M 0 222 0 D 2020-03-31 Ordinary Shares 222 7650 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2017. The price reported for the sales on November 1, 2017 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.35 to $13.3501 per share, inclusive. The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Exercise from an option award granted November 7, 2012, which became fully vested on December 31, 2016. Exercise from an option award granted February 18, 2010, which became fully vested on April 1, 2014. /s/ Elizabeth M. Keiley, as Attorney-in-Fact for Richard A. Sandberg 2017-11-02